DEA Extends Telemedicine Prescribing Flexibilities For One Year, Permanent Solution Uncertain

By Christian Robles / November 15, 2024 at 6:27 PM

The Drug Enforcement Administration will extend telemedicine prescribing of controlled substances flexibilities through 2025 in a move welcomed by top telehealth advocacy groups.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

DEA Extends Telemedicine Prescribing Flexibilities For One Year, Permanent Solution Uncertain

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.